Commercialization And Logistics

1. Regulatory Compliance And Viral Vectors 11/13/2023

   Hear from experts who detail the specific regulatory challenges for advanced therapies, as well as how the regulatory requirements differ in early research and development in academia and in industrial vector production.

2. Collaborating with the FDA: Dr. Peter Marks and Dr. Nicole Verdun Share Advice For Small And Emerging Biotechs 1/30/2024

   In this segment, Dr. Peter Marks and Dr. Nicole Verdun share their advice and best practices for small and emerging biotechs when working with the FDA.

3. How Past Gene Therapy Approvals Are Shaping the Future with Dr. Peter Marks 1/30/2024

   In this segment of Cell & Gene Live, Dr. Peter Marks shared what he and his team have learned from current gene therapy approvals to accelerate future approvals.

4. Breaking Down Automated Manufacturing 8/18/2023

   Experts explain the general benefits of automated manufacturing as well as the key areas that need improvement to scale up quality and to help reduce the costs of therapeutics.

5. An Active Release Mechanism For Magnetic Separation And Cell Isolation 11/13/2023

   Discover an innovative active release solution that will serve autologous and allogeneic processes to the benefit of cell therapy patients.

6. Technology Needs For Automated Manufacturing 8/18/2023

   Investigate the importance of technology as it relates to automation and standardization within cell therapy manufacturing. The panelists in this discussion cover solutions and services needed for process automation in CGT.

7. Driving Down COGS Audience Q&A 8/18/2023

   Expert panelists provide detailed answers to questions submitted in real time by our registrants providing insightful responses regarding analytical challenges to automation, test automation, and more.

8. Improvements In Scaling And Sequencing For Allogeneic Cell Therapies For Oncology 5/6/2024

   During this segment, Nguyen and Wagner agree that scalability will be a top concern for most CGT companies.

9. Upstream To Downstream: A Comprehensive Approach To AAV Production 12/7/2023

   How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.

10. mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A 1/29/2024

    During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.